Additionally, the use of CLK inhibitors correlates with an anti‐proliferative effect in cancer lines thought to arise from altered splicing of genes associated with DNA replication, repair, and mitotic processes [44, 313, 314, 315, 316]. The gene discussed is CLK1; the disease is cancer.